192 related articles for article (PubMed ID: 38279058)
1. Rituximab alleviates pediatric systemic lupus erythematosus associated refractory immune thrombocytopenia: a case-based review.
Mu F; Bai X; Lou Y; Luo P; Guo Q
Immunol Res; 2024 Jan; ():. PubMed ID: 38279058
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
Abe K; Ishikawa Y; Ishikawa J; Fujiwara M; Kita Y
Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases.
Nakayama K; Tamimoto Y; Nakayama T
Mod Rheumatol Case Rep; 2023 Dec; 8(1):69-73. PubMed ID: 37718578
[TBL] [Abstract][Full Text] [Related]
4. A modified regimen of low-dose rituximab therapy for patients with refractory immune thrombocytopenia associated with systemic lupus erythematosus.
Zhang S; Jiang N; Wang L; Zhang L; Chen H; Li M; Zeng X
Ther Adv Chronic Dis; 2021; 12():20406223211048643. PubMed ID: 34729154
[TBL] [Abstract][Full Text] [Related]
5. Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review.
Garra W; Carmi O; Kivity S; Levy Y
Medicine (Baltimore); 2023 Feb; 102(6):e32949. PubMed ID: 36820549
[TBL] [Abstract][Full Text] [Related]
6. Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.
Song Y; Zhang Y; Li Z; Liu J; Xiao J; Song H
Ann Hematol; 2022 Jul; 101(7):1447-1456. PubMed ID: 35532821
[TBL] [Abstract][Full Text] [Related]
7. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
Ilizaliturri-Guerra O; Uriarte-Botello R; Pineda-Sic RÁ; Serna-Peña G; Garza-Elizondo MA; Galarza-Delgado DÁ; Leal-Bramasco AS; Elizondo-Solís CV; Santoyo-Fexas L; Villarreal-Alarcón MÁ
Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
[TBL] [Abstract][Full Text] [Related]
8. Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
DeCoste C; Mateos-Corral D; Lang B
Pediatr Rheumatol Online J; 2021 Jan; 19(1):7. PubMed ID: 33407629
[TBL] [Abstract][Full Text] [Related]
9. Systemic lupus erythematosus-complicating immune thrombocytopenia: From pathogenesis to treatment.
Jiang Y; Cheng Y; Ma S; Li T; Chen Z; Zuo X; Zhang X
J Autoimmun; 2022 Oct; 132():102887. PubMed ID: 36030136
[TBL] [Abstract][Full Text] [Related]
10. [Rituximab treatment for immune thrombocytopenia associated with systemic lupus erythematosus].
Lehembre S; Macario-Barrel A; Musette P; Carvalho P; Joly P
Ann Dermatol Venereol; 2006 Jan; 133(1):53-5. PubMed ID: 16495854
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X
Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618
[TBL] [Abstract][Full Text] [Related]
12. The Role of Hydroxychloroquine as a Steroid-sparing Agent in the Treatment of Immune Thrombocytopenia: A Review of the Literature.
Mohammadpour F; Kargar M; Hadjibabaie M
J Res Pharm Pract; 2018; 7(1):4-12. PubMed ID: 29755993
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia.
Zhan Y; Cheng L; Wu B; Ji L; Chen P; Li F; Cao J; Ke Y; Yuan L; Min Z; Sun L; Chen H; Hua F; Cheng Y
Ann Transl Med; 2021 Feb; 9(3):222. PubMed ID: 33708849
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
15. Successful Treatment of Systemic Lupus Erythematosus-Associated Thrombocytopenia with Eltrombopag: A Report of Two Cases and Literature Review.
Ulutaş F; Ök ZD; Uğur K; Çobankara V
Mediterr J Rheumatol; 2022 Dec; 33(4):444-448. PubMed ID: 37034371
[TBL] [Abstract][Full Text] [Related]
16. A Case of Systemic Lupus Erythematosus (SLE)-Induced Immune Thrombocytopenia Presented With a Subdural Hematoma.
Asad DM; Tos SM; Khalil OR; Khammash AH; Awesat AA; Barbarawi AM; Isa Assadi MA; Alzaatreh JK; Mohsen M; Qasem A
Cureus; 2023 Dec; 15(12):e49958. PubMed ID: 38179378
[TBL] [Abstract][Full Text] [Related]
17. Rituximab or cyclosporin in refractory immune thrombocytopenia secondary to connective tissue diseases: a real-world observational retrospective study.
Sun F; Chen J; Wu W; Geng S; Xu W; Sun S; Chen Z; Gu L; Wang X; Li T; Ye S
Clin Rheumatol; 2020 Oct; 39(10):3099-3104. PubMed ID: 32418039
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Rituximab in the Management of Pediatric Systemic Lupus Erythematosus: A Systematic Review.
Mahmoud I; Jellouli M; Boukhris I; Charfi R; Ben Tekaya A; Saidane O; Ferjani M; Hammi Y; Trabelsi S; Khalfallah N; Tekaya R; Gargah T; Abdelmoula L
J Pediatr; 2017 Aug; 187():213-219.e2. PubMed ID: 28602379
[TBL] [Abstract][Full Text] [Related]
19. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
